Treatment of susceptible bacterial infections, including chronic bronchitis (acute exacerbation), community-acquired pneumonia, sinusitis, and otitis media.
Adults:
Oral: 320 mg once daily.
IV: 200 mg once daily.
Product available in various countries; not currently available in the United States.
Solution Reconstituted, Intravenous, as mesylate: 200 mg
Tablet, Oral, as mesylate: 320 mg